Aardvark Therapeutics Inc. Common Stock

AARD | NASDAQ

$5.57

+$0.19 (+3.53%)

At close: Sep 21, 2026, 4:00 PM ET

$5.56

-$0.01 (-0.18%)

After-hours: Sep 21, 2026, 7:54 PM ET

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022
Net Income	-57.59M	-20.59M	-7.21M	-13.56M
Depreciation & Amortization	-1.31M	16K	97K	110K
Stock-Based Compensation	3.95M	439K	313K	412K
Other Working Capital	117K	775K	-857K	-1.34M
Other Non-Cash Items	421K	473K	1.06M	3.81M
Deferred Income Tax	n/a	n/a	n/a	n/a
Change in Working Capital	356K	1.57M	-81K	-1.31M
Operating Cash Flow	-54.17M	-18.09M	-5.82M	-10.54M
Capital Expenditures	-95K	-109K	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a
Purchase of Investments	-129.6M	-11.89M	n/a	n/a
Sales Maturities Of Investments	80.03M	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	-1M
Investing Cash Flow	-49.67M	-12M	n/a	-1M
Debt Repayment	n/a	n/a	n/a	-1M
Common Stock Repurchased	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	-3.34M	n/a	1M
Financial Cash Flow	89.25M	81.99M	n/a	225K
Net Cash Flow	-14.59M	51.91M	-5.82M	-11.32M
Free Cash Flow	-54.27M	-18.2M	-5.82M	-10.54M
Adj. Free Cash Flow	-58.22M	-18.64M	-6.14M	-10.96M
Maintenance CapEx	-95K	-16K	n/a	n/a
Growth CapEx	n/a	-93K	n/a	n/a
Owner Earnings	-54.27M	-18.1M	-5.82M	-10.54M